Genomic Health To Pay $32.5M In Medicare Billing FCA Deal
A clinical diagnostic test supplier will pay $32.5 million to resolve allegations that it violated the False Claims Act by skirting Medicare rules to overbill the federal government for genomic-based lab...To view the full article, register now.
Already a subscriber? Click here to view full article